Nadolol Versus Propranolol in Children With Infantile Hemangiomas
Status:
Completed
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of oral propranolol versus
nadolol in patients with Infantile Hemangiomas (IH) in a randomized, controlled,
double-blinded study.